Jump to main content
博士論文

Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation

Persistent ID (NDL)
info:ndljp/pid/11679160
Material type
博士論文
Author
島松, 淳一郎
Publisher
-
Publication date
2020-03-01
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
久留米大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

2019年度Heart and Vessels 35(3):312-322, 2020

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
島松, 淳一郎
Author Heading
Publication Date
2020-03-01
Publication Date (W3CDTF)
2020-03-01
Alternative Title
プラスグレルは、薬剤溶出性ステント留置後に長期間の抗血小板2剤併用療法を行った、cytochrome P450 2C19の遺伝的代謝異常を持つ患者において、血小板凝集能を効果的に低下させる
Degree grantor/type
久留米大学
Date Granted
2020-03-01
Date Granted (W3CDTF)
2020-03-01